Stock listing
Frankfurt:24H Hansa Biopharma AB Aktie
German listing (Frankfurt) of Hansa Biopharma AB · home listing Stockholm:HNSA
Follow Hansa Biopharma AB into a list and get an email when it puts out news.
Share price · FWB:24H
€3.47 EUR +0.19 (+5.8%)
Close on Oct 30, 2026
- Day range
- €3.46 – €3.47 EUROct 30, 2026
- Market cap
- €345.7M EURAt the close on Oct 30, 2026 · price × 99.73M shares outstanding

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:HNSA · Home | 37.84 SEK | -1.50 (-3.8%) | 835,085 | 39.38 | 40.00 | 37.66 | 39.34 | Close on Nov 2, 2026 |
| Frankfurt:24H | €3.466 EUR | +0.19 (+5.8%) | — | €3.46 | €3.466 | €3.46 | €3.276 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:24H
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 1, 2026
Hansa Biopharma Partners with Cradle to Advance AI-Driven Protein Design and Engineering
Latest earnings call · Jul 22, 2026
Hansa Biopharma (Stockholm:HNSA) Q2 2026 Earnings Call
Replay and transcript
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 24 slides
Calls
Replays
Hansa Biopharma (Stockholm:HNSA) Q2 2026 Earnings Call
Wed, Jul 22, 2026 · 8:00 AM ET
Watch TranscriptHansa Biopharma (Stockholm:HNSA) Q1 2026 Earnings Call
Thu, Apr 23, 2026 · 8:00 AM ET
Watch TranscriptHansa Biopharma (Stockholm:HNSA) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Financings
Public offering of american Depositary Shares representing ordinary shares, and ordinary shares
Aug 21, 2026
Announced: public offering
Decks
Investor Presentation (November 2026)
Investor deck · 24 slides · November 2026
Q2 2026 Earnings Presentation
Earnings · 32 slides · Jul 22, 2026
Investor Presentation (July 2026)
Investor deck · 26 slides · July 2026
Investor Day (June 2026)
Investor day · 64 slides · Jun 25, 2026
Hansa Biopharma AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 35 in all · newest Oct 1, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Jul 22, 2026
- Decks
- 43 decks · latest November 2026
Where Hansa Biopharma AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:HNSA · Home listing | Stockholm | Sweden | SEK |
| LSIN:0RC7 | LSIN | United Kingdom | SEK |
| gettex:24H | gettex | Germany | EUR |
| LS Exchange:A0M65T | LS Exchange | Germany | EUR |
| Lang & Schwarz:A0M65T | Lang & Schwarz | Germany | EUR |
| OTC:HNSBF | OTC | United States | USD |
| Aquis:HNSAS | Aquis | United Kingdom | SEK |
| Aquis:HNSAS | Aquis | United Kingdom | SEK |
| Dusseldorf:24H | Dusseldorf | Germany | EUR |
| Frankfurt:24H · This page | Frankfurt | Germany | EUR |
| Munich:24H | Munich | Germany | EUR |
| Stuttgart:24H | Stuttgart | Germany | EUR |
| Tradegate:24H | Tradegate | Germany | EUR |
| Turquoise:HNSAS | Turquoise | United Kingdom | SEK |
Log in to ask 6ix AI your own questions about Hansa Biopharma AB.